Peripheral Blood Stem Cell Transplantation Recruiting Phase 2 Trials for Pegfilgrastim (DB00019)

IndicationStatusPhase
DBCOND0038647 (Peripheral Blood Stem Cell Transplantation)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03993639KRN125 for Mobilization of Hematopoietic Stem CellsTreatment